These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34426854)

  • 1. Ethical considerations in gene selection for reproductive carrier screening.
    Dive L; Archibald AD; Newson AJ
    Hum Genet; 2022 May; 141(5):1003-1012. PubMed ID: 34426854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.
    Capalbo A; Fabiani M; Caroselli S; Poli M; Girardi L; Patassini C; Favero F; Cimadomo D; Vaiarelli A; Simon C; Rienzi LF; Ubaldi FM
    Hum Reprod; 2021 Jun; 36(7):2050-2061. PubMed ID: 34021342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. User Acceptability of Whole Exome Reproductive Carrier Testing for Consanguineous Couples in Australia.
    Josephi-Taylor S; Barlow-Stewart K; Selvanathan A; Roscioli T; Bittles A; Meiser B; Worgan L; Rajagopalan S; Colley A; Kirk EP
    J Genet Couns; 2019 Apr; 28(2):240-250. PubMed ID: 30964588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons affecting the uptake of reproductive genetic carrier screening among nonpregnant reproductive-aged women in Flanders (Belgium).
    Van Steijvoort E; Demuynck R; Peeters H; Vandecruys H; Verguts J; Peeraer K; Matthijs G; Borry P
    J Genet Couns; 2022 Oct; 31(5):1043-1053. PubMed ID: 35385167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, attitudes and preferences regarding reproductive genetic carrier screening among reproductive-aged men and women in Flanders (Belgium).
    Van Steijvoort E; Devolder H; Geysen I; Van Epperzeel S; Peeters H; Peeraer K; Matthijs G; Borry P
    Eur J Hum Genet; 2022 Nov; 30(11):1255-1261. PubMed ID: 35304601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should severity be understood in the context of reproductive genetic carrier screening?
    Dive L; Archibald AD; Freeman L; Newson AJ
    Bioethics; 2023 May; 37(4):359-366. PubMed ID: 36744627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A closer look at expanded carrier screening from a PGD perspective.
    Vaz-de-Macedo C; Harper J
    Hum Reprod; 2017 Oct; 32(10):1951-1956. PubMed ID: 28938745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should genes for non-syndromic hearing loss be included in reproductive genetic carrier screening: Views of people with a personal or family experience of deafness.
    Freeman L; Bristowe L; Kirk EP; Delatycki MB; Scully JL
    J Genet Couns; 2024 Jun; 33(3):566-577. PubMed ID: 37533186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which types of conditions should be included in reproductive genetic carrier screening? Views of parents of children with a genetic condition.
    Thomas LA; Lewis S; Massie J; Kirk EP; Archibald AD; Barlow-Stewart K; Boardman FK; Halliday J; McClaren B; Delatycki MB
    Eur J Med Genet; 2020 Dec; 63(12):104075. PubMed ID: 33007447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International perspectives on the implementation of reproductive carrier screening.
    Delatycki MB; Alkuraya F; Archibald A; Castellani C; Cornel M; Grody WW; Henneman L; Ioannides AS; Kirk E; Laing N; Lucassen A; Massie J; Schuurmans J; Thong MK; van Langen I; Zlotogora J
    Prenat Diagn; 2020 Feb; 40(3):301-310. PubMed ID: 31774570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes of the general population towards preconception expanded carrier screening for autosomal recessive disorders including inborn errors of metabolism.
    Nijmeijer SCM; Conijn T; Lakeman P; Henneman L; Wijburg FA; Haverman L
    Mol Genet Metab; 2019 Jan; 126(1):14-22. PubMed ID: 30563741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Australian Reproductive Genetic Carrier Screening Project (Mackenzie's Mission): Design and Implementation.
    Archibald AD; McClaren BJ; Caruana J; Tutty E; King EA; Halliday JL; Best S; Kanga-Parabia A; Bennetts BH; Cliffe CC; Madelli EO; Ho G; Liebelt J; Long JC; Braithwaite J; Kennedy J; Massie J; Emery JD; McGaughran J; Marum JE; Boggs K; Barlow-Stewart K; Burnett L; Dive L; Freeman L; Davis MR; Downes MJ; Wallis M; Ferrie MM; Pachter N; Scuffham PA; Casella R; Allcock RJN; Ong R; Edwards S; Righetti S; Lunke S; Lewis S; Walker SP; Boughtwood TF; Hardy T; Newson AJ; Kirk EP; Laing NG; Delatycki MB; The Mackenzie's Mission Study Team
    J Pers Med; 2022 Oct; 12(11):. PubMed ID: 36579509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethics of Reproductive Genetic Carrier Screening: From the Clinic to the Population.
    Dive L; Newson AJ
    Public Health Ethics; 2021 Jul; 14(2):202-217. PubMed ID: 34650621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening.
    Hinton CF; Grant AM; Grosse SD
    Ethn Health; 2011; 16(4-5):377-88. PubMed ID: 21797724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving landscape of expanded carrier screening: challenges and opportunities.
    Kraft SA; Duenas D; Wilfond BS; Goddard KAB
    Genet Med; 2019 Apr; 21(4):790-797. PubMed ID: 30245516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening.
    Modra LJ; Massie RJ; Delatycki MB
    Med J Aust; 2010 Aug; 193(3):157-60. PubMed ID: 20678044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First French study relative to preconception genetic testing: 1500 general population participants' opinion.
    Bonneau V; Nizon M; Latypova X; Gaultier A; Hoarau E; Bézieau S; Minguet G; Turrini M; Jourdain M; Isidor B
    Orphanet J Rare Dis; 2021 Mar; 16(1):130. PubMed ID: 33712027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "I'm Healthy, It's Not Going To Be Me": Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia.
    Beard CA; Amor DJ; Di Pietro L; Archibald AD
    Am J Med Genet A; 2016 Aug; 170(8):2052-9. PubMed ID: 27150953
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.